MaxLinear, Inc.
MXL · NASDAQ
Company research
MaxLinear, Inc. (Nasdaq: MXL) is a fabless semiconductor company headquartered in Carlsbad, California, that designs and delivers communications systems-on-chip (SoC) solutions for broadband access, connectivity, infrastructure, and industrial and multi-market applications. Founded in 2003 and led by CEO Kishore Seendripu, the company specializes in highly integrated radio frequency (RF), high-performance analog, mixed-signal, and digital signal processing integrated circuits that enable high-speed data transmission across cable modems, fiber gateways, Wi-Fi and wireline routers, optical transceivers, and 4G/5G base-station infrastructure. As a fabless chipmaker, MaxLinear outsources manufacturing to third-party foundries while focusing its expertise on chip architecture, design, and software innovation, securing revenue through design-wins with original equipment manufacturers (OEMs) and electronics distributors worldwide. With infrastructure revenue surging 136% year over year and a market capitalization of approximately $8.65 billion, MaxLinear is an increasingly prominent player in next-generation networking and AI infrastructure markets.
Research reports
Aggregates broker research indicating a consensus Hold rating and an average price target of $65.50, implying roughly 30% downside from the current share price, while noting very high valuation multiples, strong expected EPS growth, elevated short interest, and heavy institutional ownership, pointing to a cautious, valuation-sensitive stance rather than a clear buy or sell call.
Orbyd · June 28, 2026MXL stock analysis — MaxLinear, Inc.Develops a detailed thesis that MXL has transitioned from a broadband turnaround story to an AI optical/data-center silicon re‑rating after a Q1 FY26 beat and above-consensus Q2 guidance, supported by Street price target hikes to $105–$125, but emphasizes stretched near-term price action, upcoming Q2 earnings as a binary catalyst, and the Silicon Motion arbitration award as major downside risk.
FreedomCore Atlas · June 24, 2026MAXLINEAR, INC (MXL) Stock Analysis & Daily BriefOffers a narrative digest highlighting that MaxLinear’s recent SEC filings include expanded equity incentive plans while its latest 10‑Q shows continued cash burn, widening net losses, and rising inventory, arguing that investors still lack evidence of sustained revenue growth, margin recovery, or positive operating cash flow and framing the story as fundamentally challenged until the financials materially improve.
Simply Wall St · June 22, 2026MaxLinear (Nasdaq:MXL) – Stock AnalysisProvides a structured fundamental report showing strong forecast earnings growth and solid balance-sheet health but rates valuation as stretched, with the shares appearing significantly overvalued versus intrinsic value estimates, and flags high share-price volatility, insider selling, and negative trailing profitability, resulting in a balanced view that acknowledges both AI-infrastructure upside and meaningful valuation and execution risks.
Macroaxis · March 9, 2026MaxLinear Stock AnalysisConcludes that MaxLinear is undervalued relative to an estimated real value of 17.78 and a consensus target price of 21.55, despite currently negative margins and high volatility, and supports a Buy-oriented interpretation by highlighting mid-cap positioning, strong institutional ownership, moderate leverage, and improving capital-efficiency metrics, while noting that weak profitability and elevated risk must be weighed in any investment decision.
AnalyStock.ai · November 22, 2025MaxLinear, Inc. (MXL) Investment Case ReportLong-form PDF investment case that synthesizes SEC financials, segment data, and proprietary scoring into a narrative where MaxLinear is positioned for growth in broadband, infrastructure, connectivity and industrial markets, but carries an A‑Score of 3.55/10, persistent GAAP losses, concentration risks, and only moderate quality and valuation scores, leading to an analytical but non-prescriptive view with significant upside and downside identified rather than a clear recommendation.